Pre-exposure Prophylaxis for HIV Infection: Preventing Disease or Promoting Sexual Health?
Practitioners of public health recognize that disease prevention and health promotion occupy the same continuum of activities that are aimed at improving individual and population health. Closely related as they are, however, these two domains are not identical—either in concept or in practice. Their differences owe to the widely-accepted definition of health as a state of “complete physical, mental and social well-being and not merely the absence of disease or infirmity” . Namely, while the absence of disease brought about by prevention activities is a laudable goal and an important component of health, it may not be the only condition necessary to achieve and sustain overall health.
This observation is especially pertinent when considering the domain of sexual health. Admittedly, definitions of sexual health have evolved over time and will continue to develop as our understanding of human sexuality grows . Nevertheless, the following elements are currently recognized as...
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.World Health Organization. (1946). Constitution of the World Health Organization. Retrieved Oct 25, 2018, from https://www.who.int/about/mission/en/.
- 3.World Health Organization. (2010). Developing sexual health programs: A framework for action. Retrieved Oct 29, 2018, from https://www.who.int/reproductivehealth/publications/sexual_health/rhr_hrp_10...en/.
- 6.Smith, D. K., Grant, R. M., Weidle, P. J., Lansky, A., Mermin, J., & Fenton, K. A. (2011). Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. Morbidity and Mortality Weekly Report, 60(3), 65–68.Google Scholar
- 7.Smith, D. K., Thigpen, M. C., Nesheim, S. R., et al. (2012). Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. Morbidity and Mortality Weekly Report, 61(31), 586–589.Google Scholar
- 8.Smith, D. K., Martin, M., Lansky, A., Mermin, J., & Choopanya, K. (2013). Update to interim guidance for preexposure prophylaxis (PrEP) for the prevention of HIV infection: PrEP for injecting drug users. Morbidity and Mortality Weekly Report, 62(23), 463–465.Google Scholar
- 9.Food and Drug Administration. (2012). FDA approves first drug for reducing the risk of sexually acquired HIV infection. Retrieved Oct 31, 2018, from https://aidsinfo.nih.gov/news/1254/fda-approves-first-drug-for-reducing-the-risk-of-sexually-acquired-hiv-infection.
- 10.Centers for Disease Control and Prevention: US Public Health Service. (2014). Preexposure Prophylaxis for the Prevention of HIV Infection in the United States: A Clinical Practice Guideline. Published May 14, 2014. Note: 2014 PrEP Guidelines are no longer maintained by CDC.Google Scholar
- 11.Ryan, B. (2018). FDA Approves Truvada as PrEP for Adolescents at Risk for HIV. POZ. Retrieved Nov 1, 2018, from https://www.poz.com/articel/fda-approves-truvada-prep-adolescents-risk-hiv.
- 12.Office of National AIDS Policy. (2015). National HIV/AIDS Strategy for the United States: Updated to 2020. Retrieved Nov 3, 2018, from https://obamawhitehouse.archives.gov/sites/default/files/docs/national_hiv_aids_strategy_update_2020.pdf.
- 13.Jenness, S. M., Goodreau, S. M., Rosenberg, E., Beylerian, E. N., Hoover, K. W., Smith, D. K., & Sullivan, P. (2016). Impact of the Centers for Disease Control’s HIV preexposure prophylaxis guidelines for men who have sex with men in the United States. Journal of Infectious Diseases, 214(12), 1800–1807.CrossRefGoogle Scholar
- 14.Sullivan, P. S., Giler, R. M., Mouhanna, F., et al. (2018). Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017. Annals of Epidemiology, 12(12), 833-840.Google Scholar
- 16.Harawa, N., McBride, S., Leibowitz, A., Pulsipher, C., & Holloway, I. (2018). Examining PrEP Uptake among Medi-Cal Beneficiaries in California: Differences by Age, Gender, Race/Ethnicity and Geographic Region. California HIV/AIDS Policy Research Centers. Retrieved Nov 5, 2018, from http://www.chprc.org/examining-prep-uptake-among-medi-cal-beneficiaries-in-california/.
- 20.Eaton, L. A., Kalichman, S. C., Price, D., Finneran, S., Allen, A., & Maksut, J. (2017). Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among black and white men and transgender women who have sex with men. AIDS and Behavior, 21(5), 1236–1246.CrossRefGoogle Scholar
- 22.Eaton, L. A., Driffin, D. D., Smith, H., Conway-Washington, C., White, D., & Cherry, C. (2014). Psycho-social factors related to willingness to use pre-exposure prophylaxis for HIV prevention among black men who have sex with men attending a community event. Sexual Health, 11(3), 244–251.CrossRefGoogle Scholar
- 24.Cahill, S., Taylor, S. W., Elesser, S. A., Mena, L., Hickson, D., & Mayer, K. H. (2017). Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care, 29(11), 1351–1358.CrossRefGoogle Scholar
- 27.Pathela, P., Jamison, K., Braunstein, S. L., Schillinger, J. A., Varma, J. K., & Blank, S. (2017). Incidence and predictors of HIV infection among men who have sex with men attending public sexually transmitted disease clinics, New York City, 2007–2012. AIDS and Behavior, 21(5), 1444–1451.CrossRefGoogle Scholar
- 31.National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. (2018). New CDC analysis shows steep and sustained increases in STDs in recent years. Retrieved Nov 28, 2018, from http://www.cdc.gov/nchstp/newsroom/2018/press-release-2018-std-prevention-conference.html.
- 32.U. S. Office of Disease Prevention and Health Promotion. Healthy People 2020: Public Health Infrastructure. Retrieved Nov 29, 2018, from https://www.healthypeople.gov/2020/topics-objectives/topic/public-health-infrastructure.
- 34.Parisi, D., Warren, B., Leung, S. Y., Akkaya-Hocagil, T., Qin, Q., Hahn, I., & Stevens, L. (2018). A multicomponent approach to evaluating a pre-exposure prophylaxis (PrEP) implementation program in five agencies in New York. Journal of the Association of Nurses in AIDS Care, 29(1), 10–19.CrossRefGoogle Scholar
- 35.New York State Department of Health. PrEP Assistance Program (PrEP-AP). Retrieved Dec 4, 2018, from https://www.health.ny.gov/diseases/aids/general/prep/prep-ap_provider.htm.
- 39.United Nations General Assembly. (2016). Political declaration on HIV and AIDS: On the fast track to accelerating the fight against HIV and to ending the AIDS Epidemic by 2030. Retrieved Dec 6, 2018, from http://www.unaids.org/sites/default/files/media-asset/2016-political-declaration-HIV-AIDS_en.pdf.